NYU Langone Health: First Molecular Test in the U.S. to Better Detect Brain Tumors Now Available to Patients
October 28, 2019
October 28, 2019
NEW YORK, Oct. 28 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
NYU Langone Health and its Perlmutter Cancer Center have launched clinical whole-genome DNA methylation profiling for patients with brain tumors.
This leading-edge molecular assay utilizes DNA epigenetic signatures and artificial intelligence with machine learning to correctly identify and subtype brain tumors. NYU Langone is the fi . . .
NYU Langone Health and its Perlmutter Cancer Center have launched clinical whole-genome DNA methylation profiling for patients with brain tumors.
This leading-edge molecular assay utilizes DNA epigenetic signatures and artificial intelligence with machine learning to correctly identify and subtype brain tumors. NYU Langone is the fi . . .